Evaluation of OPC-17116 against important pathogens that cause respiratory tract infections.

The antibacterial activity of OPC-17116, a new fluoroquinolone antibacterial agent, against important pathogens that cause respiratory tract infections was evaluated in vitro and in vivo and compared with those of ciprofloxacin, ofloxacin, and norfloxacin. The pharmacokinetic profiles of OPC-17116 w...

Full description

Bibliographic Details

Published in:	Antimicrob Agents Chemother
Main Authors:	Wakebe, H, Imada, T, Yoneda, H, Mukai, F, Ohguro, K, Ohmori, K, Tamaoka, H, Yabuuchi, Y
Format:	Artigo
Language:	Inglês
Published:	American Society for Microbiology (ASM) 1994
Subjects:	Research Article
Online Access:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284741/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7840567/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.10.2340
Tags:	Add Tag No Tags, Be the first to tag this record!